Hologic, Inc. (NASDAQ:HOLX)
The Company is a developer, manufacturer and supplier of diagnostic and medical imaging systems primarily dedicated to serving the healthcare needs of women.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Tomosynthesis will replace traditional mammograms. It's more accurate and easier to read. With every woman over 40 (or 50, depending on who you ask) getting mammograms every year there's a lot of profit to be had.
Recs
This womenshealth specialist will benefit from increased emphasis on health in general and womens health, in particular. Unlike the fake claims of Planned Parenthood, HOLX does address relevant issues of womens health. It is pre-eminent in the Liquid Based Pap test arena which is supplanting the classical Pap test and being extended throughout the world as women's rights increase in much of the (non-Muslim) third world. It is also the leader in digital mammography and specialized surgical procedures.
Recs
Excellent future prospects.
Recs
Specializes in women's health care. Currently exposure to emerging markets is small. There is huge growth opportunity for these products in developing countries like China and Brazil.
Recs
2011 Forbes Special Edition
Recs
Recs
Good Fundamentals, Niche Market
Recs
Recently upgraded to Top Pick, for whatever that's worth
Recs
Hologic, the leader in womens healthcare in over nine sectors.. John Cumming was possibly the greatest CEO in womens healthcare and maybe the most successful as well.. Future acquisitions, global expansion, and Tomo approval will help company grow.. I don't see the company continuing like this forever. Rob C. the new Ceo doesnt have the same vision.
Recs
low relative PE, good star & 2010 earnings. Bottom fishing week of 11/9
Recs
Hopping on with takover rumors should push the stock to at least $25
Recs
demand great for product
Recs
HOLX
Recs
healthcare $ go to good co's
Recs
On 11/18/08, a 5 star stock that is down more than 60 % from its yearly high but recent momentum.
Recs
Biotech sector will et a boost from Obama
Recs
As the worldwide middle class grows demand for health care will increase as will demand for HOLX cutting edge products.
Recs
Because the Dems will gain seats in congress and they will pass a single payer health plan which will cause 50 million people to go to the doctor. This will mean allot of people will need to have tests done and somebody has got to build the equipment for the tests.
Recs
Merger with Cystyc has had its bumps and will show great benefit when combined with the pruchase of Third Wave and its Invader technology. The marriage of ThinPrep and TWT's HPV testing will be a growth driver with recurring income for the forceable future.
Recs
Good long-term strategy
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 91 : 1 2 3 4 5 Next »